MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS

In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus. Dans un mode de réalisation, la présente invention concerne un composé de formule : ou un sel pharmace...

Full description

Saved in:
Bibliographic Details
Main Authors BELL, MICHAEL GREGORY, MINGUEZ ORTEGA, JOSE MIGUEL, GERNERT, DOUGLAS LINN, WOERLY, ERIC MICHAEL, BAUER, RENATO ALEJANDRO, CUMMING, GRAHAM ROBERT, KAOUDI, TALBI ABELKADER, HO, JOSEPH DANIEL, MASQUELIN, THIERRY JEAN, RODRIGUEZ HERGUETA, ANTONIO, CHEN, QI, AGEJAS CHICHARRO, FRANCISCO JAVIER, FIELDS, TODD, PRIEGO SOLER, JULIAN
Format Patent
LanguageEnglish
French
Published 24.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus. Dans un mode de réalisation, la présente invention concerne un composé de formule : ou un sel pharmaceutiquement acceptable de celui-ci, et des méthodes d'utilisation de ce composé pour le traitement du diabète sucré de type II.
Bibliography:Application Number: CA20223218345